| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Hadassah Medical Organization |
| Information provided by: | Hadassah Medical Organization |
| ClinicalTrials.gov Identifier: | NCT00416286 |
Purpose
The purpose of the study is to was to evaluate the anti bacterial efficacy of sustain-release Cetylpyridinium chloride varnish on orthodontic patients.
| Condition | Phase |
|
Healthy |
Phase I |
| MedlinePlus related topics: | Antibiotics |
| Drug Information available for: | Chlorides Cetylpyridinium chloride |
| Study Type: | Observational |
| Study Design: | Screening, Longitudinal, Defined Population, Prospective Study |
| Official Title: | Phase 1: To Evaluate the Antibacterial Efficacy of Sustained Release Cetylpyridinium Chloride Varnish in Orthodontic Patients |
Eligibility
| Ages Eligible for Study: | 12 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Exclusion Criteria:
Contacts and Locations| Contact: Doron Harari, DMD | 972-2-6776169 | dharari@cc.huji.ac.il |
| Hadassah Medical Organization |
| Principal Investigator: | Doron Harari, DMD | Orthodontic department, Dental school Hadassah Ein Kerem |
More Information
| Study ID Numbers: | 26-23.12.05-HMO-CTIL, 26-23.12.05, code: 1371 |
| First Received: | December 25, 2006 |
| Last Updated: | December 26, 2006 |
| ClinicalTrials.gov Identifier: | NCT00416286 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
|
|
|
|
